Get Pep'd has launched its telehealth platform, connecting adults over 40 across the United States with licensed providers for testosterone therapy, menopause-related hormone care, and peptide consultations.
More information is available at https://getpepd.com/
The platform rollout comes at a time when hormone-related changes are becoming a bigger focus in preventive and age-management care. According to the National Health Service (NHS), men’s testosterone levels typically decline by about 1% per year from around age 30, while women often experience a more significant hormonal shift during menopause, most commonly between ages 45 and 55. Get Pep’d was built to support adults through these changes by connecting them with licensed providers who can review symptoms, evaluate treatment options, and guide hormone and peptide therapy through a telehealth-based care model.
Get Pep'd's hormone therapy track includes testosterone therapy for men and estrogen and progesterone therapy for women navigating menopause, with treatment plans based on bloodwork rather than a fixed protocol. The platform also connects patients with providers for peptide consultations prescribed only when a licensed provider determines a patient's case warrants it.
The platform connects patients with an independent, nationwide network of licensed clinicians rather than practicing medicine directly. Patients begin with a complimentary 2-minute assessment, followed by provider review and, where appropriate, at-home or local lab testing. The lab-first approach is intended to give providers a clearer clinical picture before any plan is built, rather than relying solely on a patient's self-reported symptoms. Treatment is only prescribed if a licensed provider determines it is clinically appropriate, and patients are not charged unless a plan is approved.
Get Pep'd operates in all 50 states, with providers licensed in each patient's state of residence. Clinical services are provided exclusively by these independent providers, and Get Pep'd does not diagnose or prescribe directly. Ongoing communication between patients and their clinical team is available throughout the course of treatment, allowing adjustments to be made as new lab results come in.
Adults interested in a hormone or peptide assessment can find more information at https://getpepd.com/